Archive

Archive for the ‘vaccines for pregnant women’ Category

Advisory Committee on Immunization Practices June 2018 Meeting Update

Original Title: BLDG21_0023.jpg

The Advisory Committee on Immunization Practices (ACIP) held their second of three annual meetings at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA last week.  ECBT staff took advantage of the opportunity to view the meeting via webcast, and strongly encourage members of the public to take advantage of this technology in order to gain a better understanding of the deliberations that take place to ensure the ongoing safety and effectiveness of the vaccines licensed for use in the U.S.

The CDC sets the recommended immunization schedules for people of all ages in the U.S. based on recommendations from the ACIP. The ACIP establishes, updates and continually evaluates all the vaccine recommendations that are made in the United States for infants, adolescents and adults. These guidelines are considered the gold standard among healthcare providers. The ACIP consists of 15 voting members, 8 ex officio members and 30 non-voting representatives who participate voluntarily. In addition to the three meetings per year, which are open to the public, ACIP members serve on various work groups that are active throughout the year. Work groups review the latest studies on specific vaccines (including safety and efficacy reports), in order to provide recommendations to the larger committee.

Last week the ACIP voted on recommendations for influenza (flu) and anthrax vaccinations, and discussed HPV, mumps, shingles (herpes zoster), Japanese encephalitis, and pneumococcal vaccines. Votes and highlights from the discussions are detailed below.

 

Influenza (Flu) Vaccination Discussion and Vote

It will come as no surprise to our readers that the flu virus hit a brutal blow to people of all ages during the very severe 2017-18 flu season in the U.S., striking at nearly the same time nationwide.

 

Screenshot 2018-06-20 08.45.55

Influenza A (H3N2) was the predominant circulating strain and this year the effectiveness of the vaccine against this strain was approximately 24% (similar to the previous flu season). Effectiveness against the influenza A (H1N1) strain was 65% and 49% against the influenza B (Yamagata) strain.

 

 

 

Now the good news – vaccination reduced flu-related visits to healthcare providers (outpatient) by 40% among all people ages 6 months and older. Among adults, the vaccine reduced outpatient visits and hospitalizations by 22%.

Screenshot 2018-06-20 08.49.55

The ACIP listened to vaccine safety reports provided by representatives from the Food and Drug Administration (FDA), vaccine manufacturers, and the vaccine safety surveillance systems in the U.S. – the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD) which is a collaboration between CDC and nine healthcare organizations that began in 1990 and analyzes up to 10 million immunization records per year to ensure ongoing safety.  After an extensive review of the safety of this season’s flu vaccines, the ACIP confirmed that there were no vaccine safety signals of concern including anaphylaxis, narcolepsy and Guillian-Barre Syndrome, each of which received increased scrutiny due to a number of news and anecdotal reports in recent years.

The ACIP approved the following influenza recommendations for the 2018-19 season:

Everyone 6 months of age and older should be vaccinated with any licensed, age-appropriate influenza vaccine (IIV, recombinant influenza vaccine [RIV], or LAIV), as indicated. No preference is given for any one vaccine over another. In its February meeting, the ACIP once again recommended LAIV (the nasal spray vaccine known as FluMist) for healthy, non-pregnant people 2 through 49 years old during the 2018-19 season. This recommendation was made after ACIP reviewed effectiveness data presented by the manufacturers of FluMist.

Of Note: The Redbook Committee of the American Academy of Pediatrics, who typically endorses the recommendations of the ACIP, have stated a preference for the flu shot (IIV or RIV) over the nasal spray vaccine (LAIV), recommending that pediatricians only give the nasal spray as a last resort. This decision by the AAP is not without controversy as it may lead to confusion among parents and their providers. ECBT Board Member Dr. Paul Offit recently created a Medscape video explaining why he agrees with the ACIP’s decision to recommend the use of FluMist in children based on the effectiveness data.

 

Pneumococcal Vaccination Discussion

Two pneumococcal vaccines are currently recommended for all adults over the age of 65 – one dose of pneumococcal conjugate vaccine (PCV13) with a booster dose of pneumococcal polysaccharide vaccine (PPSV). ACIP is re-examining whether PCV13 should be routinely recommended for otherwise healthy older adults. Some experts believe the childhood recommendations for routine vaccination with PCV13 is sufficiently lowering the disease burden in adults by reducing the circulation of the disease in communities. In data presented to the ACIP, however, it seems there are persistent disparities in the rate of pneumococcal disease and vaccine uptake  pneumoacip062018

among minority populations and those in poverty, which puts into question whether it would be wise to eliminate the vaccine recommendation for adults.  The ACIP will continue to deliberate the data and have continued discussions into 2019.

 

Anthrax Vaccination Discussion and Vote

The anthrax vaccine is currently approved for use by the FDA for 18-65 year olds, and is usually given to select populations of adults (i.e. military). As the Department of Health and Human Services (HHS) and CDC review their plans for responding to an anthrax “mass event”, they have asked ACIP to offer guidance on how best to use the vaccine in the event of emergency. Specifically, they asked ACIP whether the anthrax vaccine would be equally effective and safe if they had to administer the vaccine in fewer or smaller doses to ensure there was enough vaccine for everyone affected.  Also under consideration was the utilization of different types of needles to be used in the event of a needle shortage. The current vaccine is given subcutaneously, not intramuscularly, like typical vaccines. Intramuscular needles are therefore more readily available.

After reviewing the data, the ACIP agreed unanimously that reduced dosing would still save lives, as would offering the vaccine intramuscularly instead of subcutaneously. There was no data, however, on whether reduced doses given intramuscularly would be equally effective. The Committee also offered their recommendations on the duration of antimicrobial treatment following vaccination. There is a new intramuscular anthrax vaccine on the horizon which may help federal agencies better plan for a possible emergency situation.

The ACIP made the following recommendations:

The intramuscular route of administration may be used if the subcutaneous route presents clinical, operational, or logistical challenges that may delay or prevent effective vaccination.

  • Should there be an inadequate supply of anthrax vaccine available for Post Exposure Prophylaxis (PEP), either 2 full doses or 3 half doses of AVA may be used to expand vaccine coverage.
  • In immunocompetent individuals 18-65 years of age, antimicrobials given in conjunction with vaccine may be discontinued at 42 days after the first vaccine dose or 2 weeks after the last vaccine dose, whichever comes later.

 

Japanese Encephalitis Vaccination Discussion

The cell culture-derived Japanese encephalitis vaccine (JE-VC) is both safe and effective, but given how few U.S. travelers contract the disease, ACIP is re-evaluating their recommendations. They are in the midst of re-evaluating the cost effectiveness of the vaccine and whether their recommendations should be more targeted. ACIP will continue deliberations at a future meeting.

 

Mumps Vaccination Discussion

Mumps outbreaks continue to crop up throughout the nation. From late 2016 through 2017, there were 56 outbreaks, which included 3,914 cases, and in 2018, there have already been 30 outbreaks, including 1,415 cases. The ACIP previously recommended the use of a 3rd dose of mumps virus-containing vaccine (MMR) for people identified at increased risk during a mumps outbreak. img_0681.pngDuring the June, 2018 ACIP meeting, the CDC provided guidance for public health officials to assist them on the use of a 3rd dose of MMR vaccine during an outbreak, including identifying groups of people at risk for acquiring mumps during an outbreak; assessing transmission in the settings to determine if groups are at increased risk; and how to implement a 3rd dose recommendation.

 

Shingles (Herpes Zoster) Vaccination Discussion

In October 2017, ACIP made recommendations for a new recombinant zoster vaccine (RZV) called Shingrix. The vaccine is recommended for the prevention of shingles and related complications for adults 50 years of age and older. It is also recommended for adults 50 and older who previously received zoster vaccine live (ZVL), and it is preferred over ZVL for the prevention of shingles and related complications.

GSK, the manufacturer of Shingrix, reported to the Committee that it is increasing the number of doses available due to high demand and shipping delays.  They are also continuing to study the safety and effectiveness of the vaccine.  The CDC also continues to monitor shingles vaccine coverage and vaccine supply. As it does with all vaccines, the CDC is using U.S. safety surveillance systems – VAERS and VSD – to monitor the shingles vaccine (RZV). VAERS is a passive system that is not designed to determine if a vaccine caused a health problem, but does help to detect unusual or unexpected patterns of adverse events that might indicate a possible safety problem with a vaccine. The CDC reported that were 680 reports to VAERS between October 20, 2017 and April 27, 2018, and the majority concerned females. There were no unusual patterns or unexpected adverse events. 48 (7%) of reports involved co-administration with 1 or more other vaccines, and the most commonly reported side effects from RZV were injection site pain and pyrexia (fever).

The CDC also reported to ACIP about VSD monitoring of the shingles vaccine.  The staff of the  VSD conducted vaccine safety studies based on questions and concerns raised from the medical literature and reports to VAERS. As of May 31, 2018, 37,303 total doses of RZV were administered at the participating VSD sites. The VSD monitoring for RZV includes high priority short-term outcomes (GBS, anaphylaxis, and acute myocardial infarction); lower priority short-term outcomes for descriptive analysis (gout, local and systematic reactions); and longer-term outcomes (potential immune-mediated diseases). Evidence of safety and effectiveness of shingles vaccine in immunocompromised is currently being reviewed.

The CDC has created a number of resources for RZV. For providers, the CDC developed a report published in MMWR on vaccine administrative errors, a Continuing Medical Education program (CME) called “You Call the Shots”, a Medscape video, web pages, webinars/conferences and fact sheets. For the public, the CDC created a vaccine information statement (VIS) on the RZV, web pages and a fact sheet.

Human Papillomavirus (HPV) Vaccination Discussion

In October 2018, the FDA is expected to complete a review of scientific studies to determine whether 9-valent HPV vaccine (GARDASIL®9) is safe and effective for use in adults ages 27 to 45. The vaccine will continue to serve as a prophylactic to prevent new infections, and is not expected to prevent progression of the disease among those who already have a HPV infection. The ACIP is also simultaneously reviewing the evidence that has been sent to the FDA and will determine whether to recommend the vaccine if and when the FDA approves the vaccine for use among mid-aged adults. Factoring into the ACIP decision will be the fact that the overall population-level benefit will be lower among mid-aged adults than among younger populations. This is due to the fact that this

stateoftheimmunion_hpv_final_fb

population may have already been exposed to HPV and thus already have an infection, or have immunity against some strains of the disease. In addition they tend to have fewer new sex partners and have several other factors that will make the vaccine less beneficial (but not without merit) for this older group than for those ages 11-12, who can be vaccinated prior to exposure.

The ACIP’s HPV work group is also continuing to review data in consideration of “harmonizing” the schedule for males and females so that both populations would be recommended up to the age of 26 instead of up to age 21 for males and up to age 26 for females and will report back to the full ACIP at a future meeting.

ECBT will keep you informed on this and other deliberations of this important committee.  

Learn more about each of these vaccines and the diseases they prevent on the Vaccinate Your Family website and Facebook page.

 

Tags: , ,

Is This Season’s Flu More Severe Than Usual or Just Highly Active?

January 13, 2018 10 comments

At this point in the flu season people often wonder if all the media hype is part of an orchestrated effort to panic people about flu, or if it is really signaling serious concern.

There are lots of flu stories in the news these days.  From reports of  74 Californian’s who’ve died from flu – five times the number seen at this point last year – to 13 school districts in TX closing due to the high number of flu cases among students, we’re left to wonder….

Is this year’s flu season more severe than usual or just highly active at the moment?

A recent CDC media briefing has helped clarify the following concerns regarding the latest flu activity in the U.S.: 

Right now, flu is widespread everywhere.  

One of the most notable differences between this season and others is in relation to the geographic spread of flu. This is the first time over the course of 13 years of surveillance data that the entire nation is experiencing widespread flu at the exact same time, as can be noted by the color of CDC’s flu surveillance map below.

FluWeeklyReportActivity is severe right now.

 

One of the ways the CDC tracks influenza activity is to record the number of lab confirmed cases of flu and hospitalizations by week. What they’ve noted is a very rapid increase in the number of people seeing their healthcare providers for flu diagnosis, along with a rapid rise in the numbers of people being hospitalized with lab confirmed flu. For instance, this week’s surveillance data indicates that there’s been 22.7 hospitalizations per 100,000 people in the U.S., which is up considerably from the 13.7 number recorded last week.

So far this season, influenza A (H3N2), has been the most prevalent strain in circulation. Unfortunately, historically it is often the strain linked to more severe illness, especially among children and older individuals above the age of 65. Interestingly enough, the current flu surveillance observations seem to be in line with two more previous H3N2 dominant seasons; the 2014-2015 and 2012-2013 seasons.WHOPHL02_small

Additionally the hospitalizations so far this season seem to be in line with other H3N2 predominant seasons, with the highest rates among those over the age of 65, those between 50-64, and children under 5 years of age.

Flu can cause mild disease in some, but severe disease and death in others.

FFF_website_Callout_FluIsSerious_social

Sadly, there have been as many as 30 pediatric deaths so far this season. While children are at great risk, there are plenty of reports of otherwise healthy adults who have been hospitalized or died from flu this season.

Peak season may have started early, but there are many more weeks to go.

Speaking to the media on behalf of the CDC on Friday, Dr.  Jernigan explained,

“If we look at the timing of the season, even if we have hit the top of the curve or the peak of the seasonal activity, it still means we have a lot more flu to go.”

He went on to suggest that there will likely be at least 11 to 13 more weeks of elevated influenza activity this season, before activity begins to subside. Even though it can take about two weeks for protection from vaccination to set in, Dr. Jernigan explained that we still have a lot of flu season to get through and that vaccination efforts should continue as long as influenza viruses are circulating.

While we are seeing a lot of H3N2 circulating now, we are also seeing H1N1 show up in states that have already had H3N2 activity. And we know that B viruses also tend to show up later in the season. Each of these strains are covered in the vaccine, so flu vaccination now can still help to prevent, or lessen the severity of flu throughout the remainder of the season.

Vaccination is our best defense.  

While flu vaccination is far from perfect, it remains our best defense. Not only can it help prevent flu, but it can also help lessen the severity of symptoms if a vaccinated person does end up getting infected.  This can reduce the chances of an individual being hospitalized or dying from flu.

flu-benefit-burden-infographic-1024px

In fact, a recent study showed that influenza vaccination reduced the risk of flu-associated death by 65% among healthy children and by 51% among children with underlying high-risk medical conditions. Another study indicated that many older adults benefit from repeated flu vaccination. When getting vaccinated in both the current and previous seasons, the study found flu vaccination was 74% effective in preventing ICU admissions in older individuals and 70% effective in preventing deaths among older adults.

Manufacturers are reporting that they’ve shipped more than 151 million doses of flu vaccine this season, so there shouldn’t be a problem finding a flu vaccine in your area.  Simply refer to the flu vaccine finder for assistance.

We won’t know preliminary flu vaccine effectiveness until February.  

Read more…

Most Popular Posts of 2017 Address Flu, Vaccine Safety, Disease Outbreaks and Maternal Vaccines

December 27, 2017 Leave a comment

As we look back at the success of the Shot of Prevention blog this past year, we’re especially grateful to our blog readers, contributors and subscribers.

Whether you’ve shared a post, shared your story, or shared your expertise, we recognize that our growth and success would not have been possible without your support. Thanks to you, our posts are helping people to make important immunization decisions for themselves and their families.

In these final days of 2017, we hope that you will revisit the top ten posts from the past year and share them with others in your social networks.  

1)  3 Things I’ve Learned Since Losing My Son To Flu

JoJo as Spiderman copy

 

It’s been eight years since Serese Marotta of Families Fighting Flu lost her five-year-old son, Joseph, to the flu. She’s not the same person she was eight years ago. Today, she sees things through a different lens as a bereaved parent. Losing a child is devastating, but she feels a responsibility to pass on some of the lessons she’s learned through her personal tragedy, which she does in her article here.

 

2)  10 Things Parents Who Don’t Vaccinate Their Kids Should Know

12244586_1518881475089295_4527321516860468835_o

In some cases, children who have suffered with a preventable disease were unvaccinated.  This could be the result of parents who did not have access to certain vaccines, parents who willfully refused a particular vaccine, or it could because they were too young to be fully vaccinated. After Riley Hughes passed away in the arms of his parents when he was just 32 days old, his parents made it their mission to educate people about the dangers of whooping cough, and promote the need for vaccination. In a plea to parents who still choose not to vaccinate, Riley’s mom posted the following list of “things to know” here.

 

3)  Even With All Our Modern Medicine I Watched My Sister Die From Flu

lizaLiza was healthy and only 49 years old when she contracted flu. She sought medical care early. She was cared for at a good hospital in a major city.  She had no other infections. And she was unvaccinated. To say that her death was a surprise to her brother is an understatement.  And yet her brother, Dr. Michael Northrop is a pediatric intensive care physician. His story traces the clinical course of Liza’s illness, and expresses the grief he felt as he helplessly watched his sister  succumbs to an illness that even modern medicine can’t always save us from. To read his story, click here.

 

4) Take It From This Mom, The Flu Is No Joke

Untitled design (1)

After her four-year old daughter is rushed to the emergency room, she writes a warning to others.  “The words just the flu need to be eradicated from our lexicon. Because this? This is the flu. There’s no ‘just’ about this. It was terrifying. It was the most helpless I’ve ever felt as a mommy. And it was potentially deadly.  All because I was too busy to get our flu shots.” Read the full story here.

 

5) Flu Vaccine Benefits Go Beyond Effectiveness of One Strain

yearly-lab-work-infographic-large

 

Amid speculation about how effective the flu vaccine will be this year, Dr. LJ Tan addresses some of the public’s most prominent concerns. He starts with a basic explanation of flu and flu vaccines, discusses the factors that play into vaccine effectiveness, and addresses rumors about this year’s flu vaccines. To gain a better understanding, read more here.

 

6) How My Sister Helped Save My Daughter From Whooping Cough

As a Medical Director responsible for Community Health and Prevention at Intermountain Healthcare in Salt Lake City, Utah, Tamara Sheffield is a huge advocate for SOTI_Pertussis_FBimmunizations. She is especially appreciative of maternal immunizations, which she considers one of today’s most promising new preventive health strategies. But her reasons go beyond her professional understanding of how maternal flu and Tdap vaccines pass on protective antibodies to newborns. Her surprising story ends with a twist involving her own daughter who nearly died from whooping cough when she was just three weeks old. Read it here.

 

7) Multiple Vaccine Oversight Committees Ensure Our Public Safety

While 2017 brought a lot of uncertainty about health services in this country, Dr. Dorit Reiss, Professor of Law at the University of California Hastings College of Law, explains 178_NFID_Vaccine_Safety_infograms_2_FINALwhy the public should remain confident in vaccine safety. In this post she reviews the specific ways in which vaccine safety is regulated in the U.S., and the oversight committees that monitor vaccines pre and post licensure. Her scrutiny explains that it would be hard to hide a problem if one existed, and that when problems do occur, they are quickly discovered and addressed. To learn more about vaccine safety oversight, read the full post here.

 

8) Why Should Vaccinated Individuals Worry About Measles Outbreaks

infographic-measles-contagious

With various measles outbreaks reported across the U.S. and the world in 2017, it’s important to understand why vaccinated individuals should be concerned. Many people mistakenly think that vaccinated individuals are not at risk during outbreaks. However, when it comes to infectious diseases like measles, one person’s decision not to vaccinate can negatively impact the health of others and this post explains how.

 

9) Five Things I’ve Learned About Vaccines Through 21 Years of Parenting

HowHerdImmunityWorksWe’ve all received plenty of unsolicited advice about how to care for our children. However, when making health decision for our families we should rely on evidence based research and credible information from reputable sources. In this post, I share five of the most important things I’ve learned about vaccines through my journey as a parent and immunization blogger. Spoiler alert: it begins with science and it ends with action.

 

10) Five Things Expectant Parents Need to Know About Vaccines in Pregnancy

SOTI-PregnancyCoverFBWhile well-meaning friends and family will provide a constant stream of advice on what to do and what to avoid while pregnant, all this information can be overwhelming. Expectant couples should rely on credible medical sources such as the CDC, the American College of Obstetricians and Gynecologists (ACOG), and the American College of Nurse Midwives. This blog post reviews the 5 things these trusted organizations say about the flu and Tdap vaccines routinely recommended during pregnancy. Learn more here.

 

We hope you have found our content to be engaging and informative.  We have exciting changes planned for Shot of Prevention in 2018 in hopes of engaging even more people in these important immunization conversations in the years to come.  

If you have suggestions for topics you would like us to address in 2018, or you would like to contribute a guest post for publication, please email shotofprevention@gmail.com.

Also, if you want to receive important immunization news and join in our online discussions, be sure to “Like” our Vaccinate Your Family Facebook page, follow our @ShotofPrev Twitter feed and subscribe to Shot of Prevention by clicking the link on the top right of this page.

Thanks again for your continued support and best wishes for a happy and healthy new year!

Flu Vaccine Benefits Go Beyond Effectiveness of One Strain

December 11, 2017 3 comments
LJ TanGuest post by Litjen (LJ) Tan, MS, PhD; co-chair and co-founder of the National Adult and Influenza Immunization Summit.

 

There seems to be a lot of speculation recently about how effective the influenza (flu) vaccine will be at preventing cases of influenza this season.

We have heard suggestions that the vaccine may only be 10% effective against flu this year, that there may be mismatches in the vaccine compared to the influenza strains that are circulating, and thus, that the vaccine is not worth getting.

To address these concerns I will start with a basic explanation of flu and flu vaccines, and then discuss the factors that play into vaccine effectiveness.

First, let me say that influenza is a serious respiratory infection that is responsible for about 30% of all the respiratory infections during the winter season. When I say serious, I mean that flu can keep you down for a week or more, and you will feel completely miserable. Additionally, each year thousands of people of all ages die from flu in the U.S.; it can be very dangerous. So, that office colleague who said that he was out with the flu yesterday very likely did not have influenza. Not fully understanding the dangers of flu is why some people fail to see the value of flu prevention.  

Flu is caused by multiple strains of influenza viruses that circulate during the winter season; specifically, we have influenza type A (with the H3N2 and H1N1 strains) and influenza type B (there are two type B strains that can circulate and currently 90% appear to be the Yamagata lineage, but since it is still so early in the season and sample sizes are small, this data point may not be statistically significant). Because these strains of flu viruses can switch every season in terms of dominance, and can also mutate, manufacturers need to develop a new influenza vaccine every year and people need to be re-vaccinated each year.

To be clear, the vaccine development process is the same every year, it is just that the starting, or “seed”, vaccine virus that we immunize against has to be identified before it can be used to develop our country’s annual vaccines.

When that seed virus is identified, it is then amplified (or passaged) to develop more seed virus. Then that seed virus is further amplified to create the large quantities of vaccine virus that we ultimately need to prepare an adequate supply of vaccines to protect our population. That amplification of the seed virus, and the making of large amounts of vaccine virus, can occur in eggs, which is the more traditional way, or it can also occur in cell cultures. So there needs to be four seed viruses developed and amplified to create influenza vaccines – an H3N2 seed, an H1N1 seed, and the two B seed viruses.

So why do we keep hearing people say that this year’s flu vaccine may only be 10% effective? Where did that suggestion come from?

When we say that a flu vaccine is 10% effective, what we usually mean is that it was effective in preventing 10% of cases of influenza in those who were vaccinated. This 10% number that you may have heard is actually a data point from Australia, and it’s not against all strains of flu, but specifically against the H3N2 strain that dominated the southern hemisphere this past flu season. If you look at the Australian data for all influenza, the vaccine effectiveness goes up to 33%. Agreed, that’s not great for Australians (although, it’s still better than no protection), but is looking at the Australian data truly reflective of what might happen in the US?

It’s unlikely, and here’s why. Read more…

Flu Vaccination is a Team Sport

November 10, 2017 Leave a comment
This week, as we wrap up the Centers for Disease Control and Prevention (CDC) Flu Blog-a-thon, we hear from Serese Marotta of Families Fighting Flu about how we all pay a role in flu prevention.

Most people know that the flu is a highly contagious, vaccine-preventable disease. What they don’t always realize is that flu prevention is a team sport.

It’s great when individuals get vaccinated. In fact, the Centers for Disease Control and Prevention (CDC) recommends annual flu vaccination for everyone six months and older.  But flu vaccination is not just about us as individuals. Healthy communities rely on cooperation and coordination of everyone – from family members to healthcare professionals. 

Flu is worth preventing.  

FFF_website_Callout_FluIsSerious_social

  • According to the CDC, every year in the United States, the flu kills upwards of 56,000 people, which typically includes about 100 children. That’s more than all other vaccine-preventable diseases.
  • The CDC estimates that since 2010, hospitalizations due to flu ranged from approximately 140,000 to 710,000 cases per year, with hospitalizations of children five years of age and younger ranging from 7,000 to 26,000 cases per year.

Flu vaccination is critical to keeping our communities healthy. 

According to a recent study, the flu vaccine was found to prevent death in otherwise healthy children by as much as 65 percent. Also, it can reduce the risk of flu illness for the general population by up to 60 percent when the vaccine is well-matched to circulating strains.

The “community immunity” that is achieved when large numbers of a population vaccinate is particularly important. People in high-risk groups such as babies younger than 6 months old who are too young to receive a flu vaccination, people with compromised immune systems and pregnant women, are not only more susceptible to suffering with flu, but also more likely to suffer complications if they fall victim to flu.

We all play a role on the flu prevention team. 

Parents

superherokid_FightingFlu_HelpUsDoMore

Children are often the “spreaders” of germs in their communities, which may explain why children have the highest rate of infection from flu. On average, children miss more than 38 million school days due to flu in the U.S., which can result in medical expenses and time off from work for parents. Young children are also at higher risk of developing serious complications from the flu, including hospitalization and death. Since parents are responsible for vaccinating themselves and their children against flu, they can be considered the “Captains” of our flu prevention team. 

 

Healthcare Professionals

FFF_HealthcareProfessionalToolkit_thumbnail

Research shows that a strong recommendation for annual flu vaccination from healthcare professionals is an important factor to improving vaccination rates. Most adults believe in the importance of vaccination, but sometimes need an annual reminder to actually do it. 

That’s why Families Fighting Flu has developed a new educational resource for healthcare professionals in collaboration with the National Association of Pediatric Nurse Practitioners and HealthyWomen. Through this collaboration entitled Do You Know the Flu?, we are arming healthcare professionals with the resources they need to effectively communicate the importance of flu vaccination to patients of all ages.

School Nurses and Teachers

KFOS2

Studies have shown that high vaccination rates among school children (50 to 70%) can dramatically reduce the overall burden of disease in the entire community. Families Fighting Flu recognizes the role that school nurses and teachers play in educating school-aged children and their families. This is why we’ve developed our Keep Flu out of School program. By collaborating with the CDC, the National Foundation for Infectious Diseases, and the National Association of School Nurses, Families Fighting Flu has worked closely with a team of professionals to provide critical resources to school nurses and teachers to assist them with flu prevention efforts in their communities.

Co-Workers

Flu is not only a public health issue, but also an economic one. Flu costs the U.S. economy an estimated $10.4 billion every year. According to a recent survey released in October, roughly three out of five Americans (61%) who had the flu or flu-like symptoms admitted to leaving home while ill, which can put others at risk. It’s no doubt that many of us have experienced a sick co-worker at the office who should have stayed home, but instead is now exposing others to flu.

Teammates 

Teamwork is critical to the success of any sports team. Because team mates spend a great deal of time together, it’s not uncommon to hear about professional or collegiate sports teams that have all fallen victim to the flu during important play-off games. That’s why it’s important for athletes to get an annual flu vaccination in an effort to stay healthy and Stay in the Game™.

While we each make a personal decision about flu vaccination, it is our hope that people will recognize that a choice not to get a flu vaccine could have a profound impact on our own health, as well as the health of our families, classmates, coworkers and teammates.

While there is a “U” in flu, there is no “I” in “team”. 

Vaccinate Your Family and Families Fighting Flu are two members of the national team of flu vaccination advocates. Together, we encourage all individuals six months of age and older to get their annual flu vaccination stop that you can Stay in the Game™.

For more information, visit the Families Fighting Flu website at www.familiesfightingflu.org.

3 Things I’ve Learned Since Losing My Son to Flu

October 18, 2017 8 comments
By Serese Marotta, Chief Operating Officer, Families Fighting Flu

 

JoJo as Spiderman copy

Today is a hard day for me – it’s been eight years since I lost my five-year-old son, Joseph, to the flu.

I’m not the same person I was eight years ago. Today, I see things through a different lens as a bereaved parent. I am more compassionate, more empathic, and (generally) more understanding and patient. Losing a child is devastating, but I feel it’s my responsibility to pass on some of the lessons I’ve learned through this personal tragedy.

So here’s what I want every parent to know:

1.  Every parent wants what’s best for their children.

I’ve come to realize that vaccination is a sensitive issue for many people. Some parents believe in vaccination, while others do not. But what we all agree on is that our decisions are motivated by our desire to protect our children.

Whether it’s a post on social media, or a televised interview on the news, we often witness a difference of opinions regarding the risks and benefits of vaccines.  However, we all make the choices we do with the information we have because we want to do what we THINK is best for our children. The disconnect occurs when we don’t agree on the validity of the information that’s available to us.

It’s not really the people that are divided, it’s actually the incorrect information on vaccines that we have allowed to divide us.

As parents, we are so overwhelmed with the sheer amount of information out there, that sometimes it’s difficult to determine what’s true and what’s false. That’s why when I have conversations with people who are hesitant, or even opposed to vaccines, I find it’s best to listen to their concerns and start a mutually respectful dialogue. Attacking one another won’t help. We need to combat vaccine misinformation by providing the correct information. I don’t want a single parent to risk their child’s life, or their own, simply because they didn’t have the correct information about vaccines.

So here’s what I know for sure; across the globe, millions of children have died due to infectious diseases and continue to do so. Sadly, most of these deaths could be prevented with vaccines.  My son’s death certificate states “complications of H1N1”. I know for a fact that my child died from influenza. I also know, based on the available data from the Centers for Disease Control and Prevention (CDC), that 1,472 children have died from influenza in the United States since 2004. And I know that the flu vaccine has been safely administered in the U.S. for more than 50 years.

How do I know this? Because I made sure I got the facts and I trust the science.

2. Flu vaccines save lives.

We have vaccines for a reason. Vaccines are not created for common, non-life-threatening ailments. The fact that there is even a flu vaccine should be enough to indicate the dangers of flu. Before Joseph died, I never would have thought in a million years that flu was a threat to my healthy child. I have always vaccinated myself and my children, including for flu. Joseph passed away due to H1N1 flu, which was not included in the seasonal vaccine in 2009. The H1N1 vaccine did not become available in our community until two weeks after Joseph passed away. I do believe that if he had been vaccinated for H1N1, Joseph would likely still be here today.

Flu does not discriminate – it does not care if you’re young or old, rich or poor, healthy or immunocompromised. It’s important for people to know that flu can be a serious, even deadly, disease for anyone. Before Joseph died I was more scared of him getting hit by a car or kidnapped by a stranger. Death from flu was not even on my radar. Now I know more about flu than I ever wanted to.

During the 1918 flu pandemic, 20 to 50 million people lost their lives. Every year in the U.S., upwards of 56,000 people lose their lives due to flu, including approximately 100 children. As parents, we do everything we can to keep our children safe. So why wouldn’t we protect them from the flu, too?  The flu can kill even a healthy individual. But those who are vaccinated are much less likely to die from flu.

CDC_Flu_Facts_Twitter_Blue_large

3.  Grief is not a linear process.

Read more…

What Signals the Start of Flu Season?

October 2, 2017 1 comment

Vaccinate-Family-300x250

One might think that flu season starts with the arrival of vaccine in the local pharmacy or provider’s office.  Others might believe that flu season in the U.S. begins with the first case of lab verified flu.  While flu viruses are most common during the fall and winter months,  influenza activity can begin as early as September or October and last as late as May.

The CDC monitors certain key flu indicators (like outpatient visits of influenza-like illness, lab results and reports of flu hospitalizations and deaths). When these indicators rise and remain elevated for a number of consecutive weeks, than “flu season” is said to have begun.

In preparation for flu season, the Centers for Disease Control and Prevention (CDC) and the National Foundation for Infectious Diseases (NFID) kick off their annual flu vaccine campaign each September with a special press conference which emphasizes the importance of flu vaccination.

The reality is that influenza is difficult to predict. No one knows when it will peak, how many people will suffer or die, or even how effective the flu vaccine will be.

However, what experts do know is that the flu is inevitable, yet preventable.  Every year there is suffering, hospitalizations and even deaths, but much of that could be prevented if more people were protected through annual vaccination.  2017 Flu News LBE

 

Flu is a fickle and unpredictable virus. 

This was the message Dr. Bill Schaffner delivered during the news conference last week.  Since 2010, flu-related hospitalizations in the U.S. typically range from 140,000 to 710,000 each year, killing between 12,000 and 56,000 people each year.  While the exact number may differ drastically from year to year, this just highlights how dangerous and unpredictable influenza is.

Now is the ideal time to get a flu shot. You want to be vaccinated weeks before possible exposure, because it can take about two weeks post-vaccination for your body to build the proper immune response from the vaccine.

Everyone should consider flu vaccination – even healthy individuals.

Flu Fact of the Week

The flu vaccine is recommended for everyone 6 months and older.  It not only helps to reduce the risk of flu illness and serious complications for the person getting vaccinated, but it also helps to reduce the amount of flu circulating in the community.  By reducing the incidence of flu, we can help protect those who might be more susceptible to serious flu illness, such as young infants too young to get vaccinated, pregnant women and older individuals who may be more susceptible to flu infection, and individuals with certain medical conditions, like heart disease, asthma and diabetes, who are at increased risk of complications from flu.

Too often people mistakenly believe that if they are healthy they don’t need a flu vaccine.  Or, they don’t realize how dangerous the flu can be and consider it akin to a bad cold.  However, influenza is a contagious respiratory illness with no cure.  Once the virus takes hold, all we can do is treat the symptoms.  While antiviral drugs are recommended to try to lessen symptoms and shorten the time one is stick by a day or two, the reality is that influenza must run it’s course.  This is why Dr. Northrop could do nothing but watch while his otherwise healthy adult sister succumbed to influenza and died.

Why choose vaccination if it can’t guarantee you won’t get flu?  

We often hear people explain that they won’t get a flu shot because it doesn’t guarantee that they won’t get the flu.  While it is true that the flu vaccine isn’t a 100% guarantee, the annual flu vaccine is  typcially about 40-60% effective.  Therefore, getting your annual flu vaccine means you will reduce your chances of getting the flu by 40% to 60% as compared to someone who does not get vaccinated. It also means that flu vaccination can significantly reduce the risk of flu-associated hospitalization and death (especially among children and older adults).

As an example, last year’s flu vaccine effectiveness was deemed to be approximately 42% effective overall.  While that may not sound overly impressive, it is estimated that flu vaccination last year prevented about 5.4 million cases, 2.7 million flu-related doctor’s visits and 86,000 hospitalizations last season.  But last year only about 46.8% of the U.S. population 6 months and older received a flu vaccine. Now imagine if more people had been vaccinated. The CDC estimates that if overall flu vaccination coverage had been just 5 percentage points higher, another 490,000 illnesses and 7,000 hospitalizations could have been prevented.

What determines flu vaccine effectiveness?  

Read more…